Related Experiment Video
Updated: Jul 11, 2025

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Intracranial Atherosclerosis Disease Associated With Cognitive Impairment and Dementia: Systematic Review and
Behnam Sabayan1,2, Roham Goudarzi3, Yuekai Ji2
1Department of Neurology, Hennepin Healthcare Research Institute Hennepin County Medical Center Minneapolis MN.
Insights
Intracranial atherosclerosis disease (ICAD) is linked to cognitive impairment and dementia. This systematic review confirms the association across diverse populations, highlighting the need for tailored dementia prevention in ICAD patients.
Area of Science:
- Neurology
- Cerebrovascular Diseases
- Cognitive Neuroscience
Background:
- Intracranial atherosclerosis disease (ICAD) impacts brain blood flow and structure.
- Existing research on the link between ICAD and cognitive decline presents conflicting findings.
- A comprehensive review is needed to clarify the association.
Purpose of the Study:
- To systematically review and synthesize evidence on the relationship between ICAD and cognitive impairment.
- To evaluate the consistency of findings across different study designs and populations.
Main Methods:
- A systematic literature search was conducted across major databases (PubMed, EMBASE, PsycInfo, Web of Science) from 2000 to 2023.
- Included studies were cross-sectional, prospective cohort, and postmortem studies investigating ICAD (≥50% stenosis) and cognitive outcomes.
- Data from 22 unique studies involving 11,184 individuals were analyzed.
Main Results:
- A significant association between ICAD and cognitive impairment was found in 70% of cross-sectional and 71% of prospective studies.
- Pooled analysis revealed ICAD is associated with greater cognitive impairment (OR, 1.87 [95% CI, 1.49-2.35]).
- Postmortem studies indicated a higher ICAD burden in patients with Alzheimer disease and vascular dementia compared to controls.
Conclusions:
- Intracranial atherosclerosis disease is significantly associated with cognitive impairment and dementia.
- This association is consistent across various age, sex, and racial groups.
- Findings emphasize the importance of personalized dementia prevention strategies for individuals with ICAD.
Background:
Intracranial atherosclerosis disease (ICAD) alters cerebrovascular hemodynamics and brain structural integrity. Multiple studies have evaluated the link between ICAD and cognitive impairment, with mixed results. This study aims to systematically review and summarize the current evidence on this link.
Methods And Results:
PubMed, EMBASE, PsycInfo, and Web of Science were searched from 2000 to 2023 without language restriction. Cross-sectional and prospective cohort studies as well as postmortem studies were included. Studies containing data on the link between ICAD, defined as at least 50% stenosis in 1 intracranial vessel, and cognitive impairment and dementia were screened by 2 independent reviewers. A total of 22 (17 observational and 5 postmortem) unique studies, comprising 11 184 individuals (average age range, 59.8-87.6 years; 45.7% women; 36.5% Asian race), were included in the systematic review. Seven of 10 cross-sectional studies and 5 of 7 prospective studies showed a significant association between ICAD and cognitive impairment. In the pooled analysis, ICAD was associated with greater cognitive impairment (measure of association, 1.87 [95% CI, 1.49-2.35]). Meta-regression analyses did not show a significant impact of age, sex, and race. All postmortem studies showed that patients with Alzheimer disease and vascular dementia had a higher burden of ICAD compared with controls.
Conclusions:
This study shows that ICAD is associated with cognitive impairment and dementia across age, sex, and race groups. Our findings may underscore the need to develop individualized dementia preventive care plans in patients with ICAD.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Alzheimer's Disease: Treatment
Cognitive Development During Adulthood

